Use of Jianpi Jiedu Herbs in Patients with Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis

Abstract

Objective. To systematically review the effect of invigorating Pi and detoxification (Jianpi Jiedu, (JPJD)) herbs in advanced colorectal cancer (CRC) patients receiving chemotherapy. Methods. Three English and four Chinese databases were searched. Literature was screened by EndNote X7 and data were analyzed by RevMan 5.2. Results. This review comprised 12 randomized clinical studies of 701 patients. The results showed that JPJD herbs improved the therapeutic effect on Chinese medicine symptoms [risk ratio (RR) = 1.59; 95% confidence interval (CI): 1.351.88] and Karnofsky performance score [RR = 2.07; 95% CI: 1.522.82] for advanced CRC patients receiving chemotherapy, lowered the Chinese medicine symptoms' score [weighted mean difference = -2.44; 95% CI: -3.23-1.64], reduced the incidence of nausea and vomiting [RR = 0.23; 95% CI: 0.110.49], improved platelet at toxicity grades III-IV [odds ratio = 0.29; 95% CI: 0.120.74] and I-IV [RR = 0.65; 95% CI: 0.510.82], and improved white blood cell at toxicity grades III-IV [RR = 0.37; 95% CI: 0.230.58] and I-IV [RR = 0.69; 95% CI: 0.600.79]. However, the results showed no significant effect on tumor response. Conclusion. JPJD herbs can improve quality of life, relieve symptoms, and reduce adverse events of advanced CRC patients receiving chemotherapy.